Uncategorized

The Game

Back when Diabetic Investor first began we did so because back then many of the companies in this wacky world of ours weren’t covered by analysts and the few that were covered the analysts were clueless about diabetes. Today the first part has changed unfortunately the second part is alive and well. We mention this as recently we have read many analysts reports and kept wondering how such smart people...

ENOUGH

Once again, we’re mad as hell and not going to take it anymore. This morning per a press release; “LifePlus Inc. today announced that it has entered the multi-billion-dollar smart medical wearables category with the introduction of Lifeleaf - the world’s first non-invasive continuous blood glucose monitoring multi-sensor wearable device. In addition to blood glucose monitoring, the patent-pending multi-sensor device non-invasively monitors heart rate, blood pressure, respiration rate and oxygen saturation....

What has changed?

Back on February 9th shares of Tandem (NASDAQ: TNDM) closed at $2.35 and at the time the future did not look very bright. Fast forward to yesterday with shares closing at over $11. Talk about a happy dance. Yes, suddenly, this company which was on the verge of declaring bankruptcy is now flush with cash and its stock is skyrocketing. Yet when looked at without rose colored glasses what has...

Yep it’s Monday alright

As much as we wish the weekend would never end alias Monday is here once again which means it’s wacky time. Here are a just a few things that caught our eye today; 1. According to a study published in Diabetes Care there may be a correlation between … wait for it … sexual orientation and the incidence of Type 2 diabetes. This study — which was led by Heather L....

Those Pesky Facts

Since we’re in the mood to share here is another post that can shared. Second many have asked just who the West Coast Mafia is, the WCM is our term for the diabetes blogging community most whom located in the Bay Area. Now that we got that out of the way onto today’s post. The so-called “high” cost of insulin continues to get lots of attention. But as we noted yesterday...

Will the patient win?

From what we can see on Twitter the West Coast Mafia is all agog about some hearings in our nation’s capital about the “high” out of pocket of insulin. A “problem” that may or may not exist as it really depends on how “high” is defined and the reasons behind the “high”. Since we have gone around and around on this issue before let’s look at this from a different...

Which tale is it?

Looking over the results and reading through the earnings call transcript we can’t decide which fairy tale is MannKind (NASDAQ: MNKD) telling. Is MannKind the little engine that could or is it Humpty Dumpty? In many respects the MannKind tale is the tale of how our wacky world works. This is a company which at one time was the darling of the street full of promise and hope. Only to...

What would Momma Kliff do?

A few years back lots of people were wearing these WWJD bracelets. Now being a nice Jewish boy, we had no idea that WWJD stood for What Would Jesus Do. Yet with Mother’s Day being this Sunday our thoughts of course turn to Momma Kliff and we began to wonder What Would Momma Kliff do if she was part of our wacky world, which we guess she is by default...

Real Solutions not toys

Many have asked why we have decided to publish our upcoming yet to be named special report. The reason is becoming clearer by the day given what’s been going on in our wacky world. A world which has become somewhat of an arms race. A race to see who can build the coolest whiz bang toy or app. Yet try as we might to get everyone to understand this isn’t...

What now?

Yesterday Moody’s issued the following rational for their debt rating for the now independent LifeScan; “Moody's Investors Service ("Moody's) assigned a B2 Corporate Family Rating and B2-PD Probability of Default Rating to LifeScan Global Corporation ("LifeScan"). Moody's also assigned a Ba2 rating to the company's $125 million secured revolving credit facility, a B1 rating to its $1.4 billion secured term loan B and a Caa1 rating to its $350 million junior...